These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24964948)

  • 1. Valproate-related erythrodermia with reversible encephalopathy: a rare but serious adverse reaction, case report.
    Rener-Primec Z; Balkovec V
    Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(2):35-8. PubMed ID: 24964948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
    Chen L; Xu Z; Huang H
    J Clin Pharm Ther; 2022 Mar; 47(3):415-419. PubMed ID: 34462930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced encephalopathy.
    Chen WT; Yen DJ; Yu HY; Liao KK
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic rash due to antiepileptic drugs: clinical features and management.
    Pelekanos J; Camfield P; Camfield C; Gordon K
    Epilepsia; 1991; 32(4):554-9. PubMed ID: 1831121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2015 May; 177(20):945-6. PubMed ID: 26535436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephalopathy induced by levetiracetam added to valproate.
    Bauer J
    Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ring chromosome 20, hypersensitivity to valproate and hyperammonemic encephalopathy].
    Ortiz-Sáenz de Santa María MR; Barriuso-Pérez E; Soto-Alvarez MI; Moche-Loeri JA
    Rev Neurol; 2003 Oct 16-31; 37(8):733-5. PubMed ID: 14593631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.